FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 Genetic Test
Are you concerned about your immune system function? DNA Labs UAE offers the FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 Genetic Test to help diagnose and provide information about this rare autosomal recessive disorder. Read on to learn more about the test components, cost, symptoms, and diagnosis process.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test gene FERMT3.
Test Details
The FERMT3 gene is associated with a rare autosomal recessive disorder known as leukocyte adhesion deficiency type 3 (LAD3). This disorder is characterized by impaired immune system function. To analyze the FERMT3 gene for any genetic variations, NGS (Next-Generation Sequencing) genetic testing is used. NGS allows for the analysis of multiple genes simultaneously and is considered a more advanced and efficient method compared to traditional sequencing techniques.
The FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 NGS Genetic DNA Test involves obtaining a DNA sample, typically through a blood sample or cheek swab. The DNA sample is then sequenced using NGS technology to identify mutations or variants in the FERMT3 gene that may be responsible for causing LAD3. The results of the test can confirm a diagnosis of LAD3 and provide information about the specific mutations present in the FERMT3 gene.
This type of genetic testing is useful for individuals with suspected LAD3 or for carrier testing in individuals with a family history of the condition. It can also be utilized for prenatal testing in families with a known risk of LAD3 to determine if the fetus is affected. It is crucial to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.
Don’t let concerns about your immune system go unanswered. Contact DNA Labs UAE today to inquire about the FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 Genetic Test and take control of your health.
| Test Name | FERMT3 Gene Leukocyte adhesion deficiency type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FERMT3 Gene Leukocyte adhesion deficiency type 3 NGS Genetic DNA Test gene FERMT3 |
| Test Details |
The FERMT3 gene is associated with a condition called leukocyte adhesion deficiency type 3 (LAD3). LAD3 is a rare autosomal recessive disorder characterized by impaired immune system function. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. It is a more advanced and efficient method compared to traditional sequencing techniques. NGS can be used to identify mutations or variants in the FERMT3 gene that may be responsible for causing LAD3. NGS genetic testing for LAD3 involves obtaining a DNA sample, typically through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to analyze the FERMT3 gene for any genetic variations. The results of the test can help confirm a diagnosis of LAD3 and provide information about the specific mutations present in the FERMT3 gene. This type of genetic testing can be useful for individuals with suspected LAD3 or for carrier testing in individuals with a family history of the condition. It can also be used for prenatal testing in families with a known risk of LAD3 to determine if the fetus is affected. It is important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results. |
